MedPath

Sonography-guided Resection of Brain Mass Lesions

Not Applicable
Recruiting
Conditions
Tumor, Brain
Arteriovenous Malformations
Intracerebral Hematoma
Cavernoma
Interventions
Device: Sonography
Registration Number
NCT05484245
Lead Sponsor
Sklifosovsky Institute of Emergency Care
Brief Summary

Objective of the study is to determine possibilities of intraoperative sonography in detecting of various brain mass lesions, assessing extent of their resection and define indications to use ultrasound-guided needle or ultrasound wire-guided port.

Detailed Description

Intraoperative sonography is usially used in neurooncology to detect brain tumors and exclude their remnants. A few studies describe it's usage while removing hematomas or vascular malformations. Ultrasound is the only method allowing to observe brain tissue in real time. It is chip and doesn't violate surgical workflow. Main disadvantages of sonography are lengthy learning curve and poorer image quality compared to magnetic resonance imaging. Novel acoustic coupling fluid, contrast-enhanced ultrasound and elastography expanded it's effectiveness. Meanwhile problems of locating of isoechogenic lesions with poor margins and elimination of artefacts are steel actual.

Objective of the study is to determine possibilities of intraoperative sonography in detecting of various brain mass lesions, assessing extent of their resection and define indications to use ultrasound-guided needle or ultrasound wire-guided port.

A surgeon will intraoperatively locate mass lesion and assess extent of it's resection with sonography. Ultrasound scanning will be performed through the same surgical approach or at a distance through enlarged craniotomy, periodically or permanently. To facilitate approach to subcortical and deep small mass lesions ultrasound-guided needle or ultrasound wire-guided port will be used.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • all intracranial tumors
  • cavernomas
  • arteriovenous malformations
  • spontaneous (non-traumatic) intracerebral hemorrhages
  • traumatic intracerebral hemorrhages
  • supratentorial localization
  • newly diagnosed
  • age 18-100 years
  • stable hemodynamics
Exclusion Criteria
  • rapid cerebral dislocation
  • previously performed brain radiotherapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SurgerySonographyUltrasound-guided resection of brain tumors, vascular malformations and hematomas
Primary Outcome Measures
NameTimeMethod
Ultrasound features of various brain mass lesions in Mair scale (in grades)Intraoperatively

Assessment of target visibility, echogenicity, homogeneity and border demarcation in sonography and their comparison to preoperative computed tomography and magnetic resonance imaging

Secondary Outcome Measures
NameTimeMethod
Sensitivity of intraoperative sonography to detect mass lesion compared to preoperative magnetic resonance imaging or computed tomography (in percents)Intraoperatively

Sensitivity = true detection of mass lesion / (true detection of mass lesion + inability to detect mass lesion) x 100

Duration of approach to mass lesion using ultrasound-guided needle or ultrasound wire-guided port (in minutes)Intraoperatively

Only for subcortical or deep-seated mass lesions. How long did in take to reach margin of mass lesion after dural incision using ultrasound-guided needle or ultrasound wire-guided port

Duration of mass lesion removal (in minutes)Intraoperatively

How long did in take to remove mass lesion from starting of it's dissection till final evacuation

Differentiation between artefacts and residual lesion (Yes or No)Intraoperatively

Possibility of ultrasound differentiation between artefacts and residual lesion

Negative predictive value of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgery

Negative predictive value = true absence of residual mass lesion / (true absence of residual mass lesion + inability to detect residual mass lesion) x 100

Sensitivity of intraoperative sonography to detect residual mass lesion compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgery

Sensitivity = true detection of residual mass lesion / (true detection of residual mass lesion + inability to detect residual mass lesion) x 100

Accuracy of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgery

Accuracy = (true detection of residual mass lesion + true absence of residual mass lesion) / (true detection of residual mass lesion + true absence of residual mass lesion + false detection of residual mass lesion + inability to detect residual mass lesion) x 100

Specificity of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgery

Specificity = true absence of residual mass lesion / (true absence of residual mass lesion + false detection of residual mass lesion) x 100

Positive predictive value of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgery

Positive predictive value = true detection of residual mass lesion / (true detection of residual mass lesion + false detection of residual mass lesion) x 100

Extent of resection (in percents)Within 48 hours after surgery

Extent of resection = (preoperative tumor volume - postoperative tumor volume) / preoperative tumor volume x 100

Karnofsky performance status (in percents)Within 10 days after surgery

Assessment of patients' possibilities to self-service in Karnofsky Performance Status scale

Cerebral complicationsFrom admission to intensive care unit after surgery till hospital discharge, up to 365 days

Which cerebral complications arose after surgery

Trial Locations

Locations (1)

Sklifosovsky Institute of Emergency Care

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath